Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 13
- 0 vs. Q3 2023
- Portfolio value
- $888.5M
- +$430.1M (+93.8%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 917,141 | $435.9M | 49.1% | +670,891+272.4% | Added | History |
| GLDSPDR Gold Trust | ETF | 1,390,000 | $265.7M | 29.9% | +327,500+30.8% | Added | History |
| iShares MSCI India ETF46429B598 | ETF | 2,425,144 | $118.4M | 13.3% | 00.0% | Unchanged | – |
| RAPTRAPT Therapeutics, Inc. | COM | 657,899 | $16.3M | 1.8% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $10.4M | 1.2% | 00.0% | Unchanged | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $10.2M | 1.1% | 00.0% | Unchanged | History |
| MEHCQChrome Holding Co. | CLASS A COM | 10,243,122 | $9.36M | 1.1% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $9.10M | 1.0% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $8.15M | 0.9% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $3.29M | 0.4% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 992,168 | $852.3K | 0.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 87,696 | $824.3K | 0.1% | 00.0% | UnchangedConverted for a 1-for-15 split | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $3.31K | <0.1% | 00.0% | Unchanged | – |